SITC Resource Library

Immunotherapy for the Treatment of Hematologic Cancers - A Patient Resource Guide 

03-25-2019 16:22

Immunotherapy helps the immune system recognize cancer cells that have been hiding and target them for destruction. The strategy of harnessing the body's natural defense system to fight cancer, which is very different from other types of cancer treatment, holds the potential to positively affect people with every type of cancer. Immunotherapy is among the fastest growing and most promising areas of cancer research and is positively changing the way doctors treat hematologic (blood) cancers. This guide, published by Patient Resource Publishing in partnership with the Society for Immunotherapy of Cancer (SITC), provides current immunotherapy options for hematologic cancers and explains the role of the immune system in cancer treatment and what to expect while undergoing treatment. This resource also lists ongoing hematologic immunotherapy clinical trials (as of March 2019).


#Patient#SITC#PatientResourceGuides#HematologicMalignancies#2019
#Leukemia#Lymphoma#Myeloma#Bcells#Tcells#Naturalkillercells
#AdoptiveCellTherapy#Cytokines#ImmuneCheckpointInhibitors#Nivolumab
#Pembrolizumab#AdverseEvents#SideEffects#ClinicalTrials#PatientAdvocate

Statistics
0 Favorited
34 Views
1 Files
0 Shares
19 Downloads
Attachment(s)
pdf file
2019 Immunotherapy Hematologic Cancers.pdf   1.83 MB   1 version
Uploaded - 04-02-2019

Related Entries and Links

No Related Resource entered.